Quanterix, which develops high-throughput protein detection tests, filed on Thursday with the SEC to raise up to $58 million in an initial public offering.
The Lexington, MA-based company was founded in 2007 and booked $23 million in revenue for the 12 months ended September 30, 2017. It plans to list on the Nasdaq under the symbol QTRX. Quanterix filed confidentially on July 21, 2017. J.P. Morgan and Leerink Partners are the joint bookrunners on the deal. No pricing terms were disclosed.
